Sanofi, GSK receive $2.1B from U.S. to develop COVID-19 vaccine
Friday, July 31, 2020 - 09:01
in Health & Medicine
European drugmakers Sanofi and GlaxoSmithKline said Friday they will receive funding from the U.S. government to aid in the development and manufacture of their COVID-19 vaccine.